4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-21-005491
Director sold 15,635 shares at $15.75 ($246,328)
- Director acquired 15,635 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Egros Fabrice · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-18 | Exercise or conversion : show line 1 in the form | +15,635 | $7.88 | $123,204 | 31,635 | D |
| 2021-08-18 | Sale : show line 2 in the form | −15,635 | $15.75 | $246,328 | 16,000 | D |
| Open-market sales · 15,635 sh · avg $15.75 · $246,328 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-18 | Exercise or conversion : show line 3 in the form Stock Options (Right to buy) | −15,635 | 0 | D |
Loading xslF345X03/primarydocument.xml…